C. S. Richards

发表

A robotics‐assisted procedure for large scale cystic fibrosis mutation analysis

A. Beaudet, C. Richards, R. Fenwick, 1994, Human mutation.

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

Alfred A. Boyd, Benjamin B. Roa, C. Richards, 1996, Nature Genetics.

Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.

Andrew C. Adey, Asia D. Mitchell, B. O’Roak, 2023, American journal of human genetics.

Cystic fibrosis carrier screening: Issues in implementation

W. Grody, M. Watson, C. Richards, 2002, Genetics in Medicine.

Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography.

C. Richards, M. Hegde, L. Su, 2001, Genetic testing.

DMD‐specific FISH probes are diagnostically useful in the detection of female carriers of DMD gene deletions

L. Shaffer, C. Richards, A. Peier, 1997, Neurology.

A comparative study of five technologically diverse CFTR testing platforms.

Monique A Johnson, Marvin J Yoshitomi, C Sue Richards, 2007, The Journal of molecular diagnostics : JMD.

Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE

L. Shaffer, D. Nelson, C. Richards, 1994, Nature Genetics.

Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey

C. Richards, G. Palomaki, C. S. Richards, 2011, Genetics in Medicine.

Frequency of a DNA polymorphism at position Y231 in the aspartoacylase gene and its impact on DNA‐based carrier testing for Canavan disease in the Ashkenazi Jewish population

J. Demarchi, R. Alford, C. S. Richards, 1998, Human Mutation.